EA201490160A1 - Конструкции для сайленсинга гена p0 и применение - Google Patents

Конструкции для сайленсинга гена p0 и применение

Info

Publication number
EA201490160A1
EA201490160A1 EA201490160A EA201490160A EA201490160A1 EA 201490160 A1 EA201490160 A1 EA 201490160A1 EA 201490160 A EA201490160 A EA 201490160A EA 201490160 A EA201490160 A EA 201490160A EA 201490160 A1 EA201490160 A1 EA 201490160A1
Authority
EA
Eurasian Patent Office
Prior art keywords
saylensing
constructions
gene
application
sequence
Prior art date
Application number
EA201490160A
Other languages
English (en)
Other versions
EA029359B1 (ru
Inventor
Элодье Кляйн
Вероник Графф
Давид Жильмер
Вероник Бро
Ги Вейен
Марк Лефевр
Original Assignee
СЕСВандерХаве НВ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44907563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201490160(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by СЕСВандерХаве НВ filed Critical СЕСВандерХаве НВ
Publication of EA201490160A1 publication Critical patent/EA201490160A1/ru
Publication of EA029359B1 publication Critical patent/EA029359B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Настоящее изобретение относится к рекомбинантной нуклеотидной последовательности Р0 вируса BMYV, которая при транскрибировании в клетке способна образовывать последовательность двухцепочечной самокомплементарной РНК.
EA201490160A 2011-06-23 2012-06-15 Конструкции для сайленсинга гена p0 и их применение EA029359B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11171196A EP2537936A1 (en) 2011-06-23 2011-06-23 P0 gene silencing constructs and use
PCT/EP2012/061436 WO2012175420A1 (en) 2011-06-23 2012-06-15 P0 gene silencing constructs and use

Publications (2)

Publication Number Publication Date
EA201490160A1 true EA201490160A1 (ru) 2014-04-30
EA029359B1 EA029359B1 (ru) 2018-03-30

Family

ID=44907563

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490160A EA029359B1 (ru) 2011-06-23 2012-06-15 Конструкции для сайленсинга гена p0 и их применение

Country Status (17)

Country Link
US (2) US9932603B2 (ru)
EP (2) EP2537936A1 (ru)
CN (1) CN103635581B (ru)
CA (1) CA2839371A1 (ru)
CL (1) CL2013003466A1 (ru)
DK (1) DK2723873T4 (ru)
EA (1) EA029359B1 (ru)
ES (1) ES2647077T5 (ru)
HU (1) HUE035070T2 (ru)
LT (1) LT2723873T (ru)
MA (1) MA35283B1 (ru)
PL (1) PL2723873T5 (ru)
PT (1) PT2723873T (ru)
SI (1) SI2723873T1 (ru)
TN (1) TN2013000498A1 (ru)
UA (1) UA114603C2 (ru)
WO (1) WO2012175420A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015117041A1 (en) * 2014-01-30 2015-08-06 Nair Ramesh B Gene modification-mediated methods and compositions for generating dominant traits in eukaryotic systems
CN110938645A (zh) * 2019-12-17 2020-03-31 中国农业大学 一种甘蔗黄叶病毒运动蛋白表达纯化方法及其多克隆抗血清的制备
WO2021234101A1 (en) * 2020-05-20 2021-11-25 KWS SAAT SE & Co. KGaA Multiple virus resistance

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69114275T2 (de) 1990-03-02 1996-06-13 Biocem Regenerierung und genetische transformation der zuckerrübe.
US7663024B2 (en) * 1998-07-10 2010-02-16 Sesvanderhave, N.V. P15 hairpin constructs and use
EP1029923A1 (en) 1999-01-27 2000-08-23 D.J. Van Der Have B.V. Method for conveying BNYVV resistance to sugar beet plants
WO2009141446A1 (en) 2008-05-23 2009-11-26 Syngenta Participations Ag Transgenic sugar beet plants
UA106061C2 (ru) 2008-12-19 2014-07-25 Сінгента Партісіпейшнс Аг Трансгенный вариант сахарной свеклы gm rz13

Also Published As

Publication number Publication date
PT2723873T (pt) 2017-10-04
TN2013000498A1 (fr) 2015-03-30
EP2723873A1 (en) 2014-04-30
CL2013003466A1 (es) 2014-08-08
US10662438B2 (en) 2020-05-26
HUE035070T2 (en) 2018-05-02
PL2723873T5 (pl) 2020-07-13
UA114603C2 (uk) 2017-07-10
US9932603B2 (en) 2018-04-03
EP2723873B2 (en) 2020-01-15
WO2012175420A1 (en) 2012-12-27
LT2723873T (lt) 2018-02-12
DK2723873T3 (da) 2017-11-20
EP2723873B1 (en) 2017-08-09
CA2839371A1 (en) 2012-12-27
ES2647077T5 (es) 2020-10-05
CN103635581A (zh) 2014-03-12
ES2647077T3 (es) 2017-12-19
US20180265888A1 (en) 2018-09-20
EA029359B1 (ru) 2018-03-30
EP2537936A1 (en) 2012-12-26
DK2723873T4 (da) 2020-04-20
MA35283B1 (fr) 2014-07-03
US20140317779A1 (en) 2014-10-23
PL2723873T3 (pl) 2018-01-31
CN103635581B (zh) 2016-08-10
SI2723873T1 (sl) 2017-11-30

Similar Documents

Publication Publication Date Title
EA202191537A1 (ru) Композиции и способы ингибирования экспрессии генов вируса гепатита в
IL262667A (en) Nucleosides, nucleotides and modified nucleic acids, and their uses
BRPI0819526B8 (pt) Sequência de ácido nucleico de precursor de mirna artificial, construção recombinante e método para reduzir a expressão de uma sequência alvo
EA201270019A1 (ru) Двуцепочечная рнк, включенная в липидный состав и мишенью которой является ген pcsk9
HK1203077A1 (en) Modified nucleoside, nucleotide, and nucleic acid compositions
MX2021009118A (es) Composiciones y metodos para inhibir la expresion del gen alas1.
MX2018013216A (es) Composiciones y metodos para inhibir la expresion del gen de proteasa transmembrana, serina 6 (tmprss6).
EA201401337A1 (ru) Доставка в лёгкие матричной рнк
MX2021015290A (es) Composiciones y metodos para inhibicion de genes para apolipoproteina c-iii (apoc3).
MX337984B (es) Variantes de alfa amilasa y polinucleotidos que codifican la misma.
MX356625B (es) Oligonucleotidos para elaborar un cambio en la secuencia de una molécula de ácido ribonucleico objetivo presente en una célula viva.
WO2013012921A3 (en) Nucleic acid aptamers
EP2377928A3 (en) Novel T7 RNA polymerase variants with enhanced thermostability
WO2012083969A3 (en) Microrna for diagnosis of pancreatic cancer
WO2014144942A3 (en) Dnai for the modulation of genes
EA201690685A1 (ru) Композиции и способы ингибирования экспрессии гена alas1
WO2014140347A3 (en) Novel nucleic acid molecules
IN2014CN03921A (ru)
EA201490160A1 (ru) Конструкции для сайленсинга гена p0 и применение
WO2011001086A3 (fr) Utilisation d'arn interferents pour le traitement d'une infection par le vih
EP2558117A4 (en) EXPRESSION OF POSITIVELY SENSING INTRODUCING RNA VIRUSES AND USES THEREOF
TW201129365A (en) Compositions and methods for inhibiting expression of IKK2 genes

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG TJ TM